New Enterprise Associates, Inc. is a private equity and venture capital firm founded in 1977 and headquartered in Menlo Park, California, with additional offices in India and China. The firm specializes in investing across various stages of business development, from seed funding to public offerings, with a strong emphasis on the technology and healthcare sectors. Its investment strategy encompasses a wide range of industries, including information technology, consumer internet, financial technology, software, healthcare services, life sciences, biopharmaceuticals, and energy technology. New Enterprise Associates actively engages with entrepreneurs to support the growth of their companies, making investments between $0.05 million and $20 million. The firm has a global investment focus, particularly in regions such as Asia, Brazil, and the United States.
Sana is an AI company building AI for enterprise knowledge.
Zenas BioPharma
Series C in 2024
Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients. The company is headquartered in Florida, USA.
Perplexity
Venture Round in 2024
Perplexity is an innovative search engine platform that leverages artificial intelligence, specifically integrating large language models with traditional search functionalities. Utilizing advanced natural language processing and generative AI technologies, Perplexity aims to deliver conversational and contextually relevant responses to user inquiries. The platform is designed to merge the capabilities of conventional search engines with interactive AI assistance, enhancing the user experience. Additionally, Perplexity promotes an open-source environment that facilitates skill development and knowledge acquisition in software development, making its tools accessible to a broader audience. This approach positions Perplexity as a key player in the evolution of AI-driven search technologies.
Inkitt
Series C in 2024
Inkitt GmbH operates an online community that connects writers and readers, facilitating the sharing and promotion of stories across various genres, including horror, romance, and sci-fi. Founded in 2013 and based in Berlin, the company publishes books using crowd wisdom and data-driven insights to predict future bestsellers. Its core platform, Inkitt, allows authors to share their works in progress and receive feedback from readers, who can access these manuscripts for free for a limited time. In addition to Inkitt, the company also operates Galatea, which sells optimized stories in a chapter-by-chapter format, and GalateaTV, which adapts successful e-books into short-form television series. Inkitt's proprietary ReadRank algorithm identifies high-potential stories, enhancing the overall user experience and driving its publishing success. The company aims to leverage AI for hyper-personalization, tailoring stories to individual reader preferences across multiple media formats.
Pair Eyewear
Series C in 2023
Pair Eyewear, founded in 2017 and based in New York, specializes in customizable eyeglasses for children. The company offers a unique product line that includes base frames, which are standard glasses, and top frames, which are snap-on fronts that can be easily changed to reflect a child's evolving interests and personalities. By leveraging an e-commerce platform, Pair Eyewear aims to transform the eyeglass experience into an engaging activity for children while simplifying the process for parents. The brand focuses on quality and affordability, providing eyewear that combines style with functionality, featuring hand-polished acetate frames and shatterproof polycarbonate lenses.
Pulumi
Series C in 2023
Pulumi is a Seattle-based cloud engineering company that offers a way to build, connect, and run modern cloud applications. Pulumi provides the cloud development model: helping Development and DevOps teams get their code to the cloud quickly and collaboratively. Pulumi provides frameworks and libraries to define, deploy, and manage cloud services -- from serverless to container to virtual machines -- using pure code, for any cloud, with clear collaboration for teams and enterprises delivering on the cloud, multi-cloud, and cloud-native application delivery strategies.
Spyglass Pharma
Series C in 2023
Spyglass Pharma specializes in developing innovative treatments for chronic ophthalmic diseases, leveraging advanced technology to enhance patient care and vision. The company focuses on creating ophthalmic devices and a drug delivery platform that addresses unmet needs in areas such as cataracts and lens replacement surgeries. Its delivery system is designed to be implanted alongside intraocular lenses during standard cataract procedures, allowing surgeons to administer multi-year therapies for chronic conditions. This approach aims to improve the accessibility and affordability of quality eye treatments for patients, ensuring better outcomes in ophthalmic care.
Instabase
Series C in 2023
Instabase, Inc. is a technology company that develops a platform aimed at automating document processing workflows and analyzing unstructured data. Founded in 2015 and based in San Francisco, California, the company provides a range of services, including optical character recognition, data classification and extraction, and natural language processing. Its platform is designed to help organizations in various sectors, such as insurance, finance, and healthcare, streamline operations and improve decision-making. By enabling businesses to embed artificial intelligence into their systems and processes, Instabase facilitates the development of applications that address significant operational challenges, particularly in the realm of intelligent document processing.
Strive Health
Series C in 2023
Strive Health, LLC, founded in 2018 and based in Denver, Colorado, specializes in solutions for chronic kidney disease. The company operates dialysis centers and employs a technology-enhanced clinical model to improve patient outcomes and experiences. Strive Health works collaboratively with innovative payers and providers to transform kidney care by focusing on the entire healthcare journey of chronic kidney disease patients, from primary care engagement to dialysis treatment. The company utilizes predictive analytics and comparative data to identify at-risk patients and aims to reinvent primary care to address kidney disease proactively, reducing the need for inpatient services and promoting home dialysis options. Backed by notable investors, Strive Health is committed to enhancing the management and care of patients with chronic kidney disease.
Mojo Vision
Series C in 2023
Mojo Vision Inc. is a company based in Saratoga, California, established in 2015, that specializes in augmented reality technology. The firm is focused on developing high-performance micro-LED displays for various applications, including consumer, enterprise, and government sectors. It has created the world's smallest and densest dynamic display integrated into a smart contact lens, designed to provide users with timely information without disrupting their focus. This innovative product allows for hands-free connectivity and access to relevant information, thereby minimizing reliance on traditional mobile devices. Additionally, Mojo Vision has formed a joint development agreement with Menicon Co., Ltd. to explore smart contact lens products further, leveraging its advanced micro-LED technology and manufacturing processes to disrupt the display industry.
Outrider
Series C in 2023
Outrider, Inc. is a software company that specializes in automating logistics hubs through the use of electric, self-driving trucks. Established in 2017 and based in Golden, Colorado, Outrider provides a software-as-a-service (SaaS) solution designed for customer-owned freight and transportation fleets. The company offers a comprehensive system comprised of web-based management software, autonomous driving controls for electric yard trucks, and necessary site infrastructure. Its technology automates various yard operations, including the movement of trailers and the engagement and disengagement of trailer connections, thereby eliminating hazardous and repetitive manual tasks. By focusing on the development of zero-emission systems, Outrider aims to enhance safety and efficiency for large enterprises reliant on logistics.
Escient Pharmaceuticals
Series C in 2022
Escient Pharmaceuticals is a biotechnology company based in San Diego, California, that develops and manufactures drugs targeting G protein-coupled receptors (GPCRs) for the treatment of neuro-immuno-inflammatory and autoreactive diseases. Founded in 2017, the company specializes in harnessing the therapeutic potential of specific orphan GPCRs, particularly the Mas-Related G-Protein Receptors (Mrgprs), to address various neurosensory-inflammatory disorders. Escient's innovative approach aims to provide first-in-class therapies for conditions associated with mast cell-mediated disorders and cholestatic pruritus, thereby expanding treatment options for healthcare providers and patients facing these challenging diseases.
Inversago Pharma
Series C in 2022
Inversago Pharma Inc. is a preclinical-stage biotechnology company based in Montreal, Canada, focused on developing innovative therapies targeting metabolic and fibrotic disorders. The company specializes in peripherally-restricted CB1 receptor inverse agonists, which aim to offer new treatment options for conditions such as Prader-Willi syndrome, diabetes, and related metabolic disorders. Inversago Pharma's research includes addressing complications associated with diabetic kidney disease, non-alcoholic steatohepatitis, and various fibrotic diseases, including interstitial lung disease. Founded in 2015, the company is dedicated to enhancing patient outcomes through its pioneering approach to CB1 blockade.
Moximed
Series C in 2022
Moximed, Inc. is a medical technology company based in Hayward, California, focused on developing innovative solutions for patients with knee osteoarthritis. The company offers the Atlas System, an implantable joint unloader designed to alleviate pain for individuals suffering from medial compartment knee osteoarthritis. This system operates similarly to a shock absorber, providing dynamic load reduction to minimize joint pain and enhance mobility. Moximed also features the MISHA Knee System, which offers an outpatient treatment option for patients who have not found relief through other therapies and are not suitable candidates for knee replacement surgery. By addressing the specific needs of osteoarthritis patients, Moximed aims to improve their quality of life while potentially delaying the need for more invasive surgical interventions. Founded in 2006, the company serves patients and medical professionals worldwide.
Super
Series C in 2022
Super is a social commerce platform that enables leaders to become self-made entrepreneurs and builds logistics networks. The company features Superagen, an agent-led commerce group buying that enables community leaders to become retailers within their communities.
Genies
Series C in 2022
Genies, Inc. is a company that specializes in avatar technology to enhance social media and messaging applications. Founded in 2011 and based in Venice, California, Genies enables users to create personalized digital avatars, which can be utilized for self-expression and interaction in various digital environments. The company has gained traction with cultural influencers and has established partnerships with major music labels, serving as the official avatar provider for artists. Genies recently expanded its offerings with an Augmented Reality (AR) Developer Kit, allowing developers to create interoperable avatar experiences. Their platform includes features for designing digital fashion and engaging in avatar-based interactive experiences. By leveraging its unique technology, Genies facilitates brand engagement and the sale of digital goods, appealing particularly to the college demographic and millennial audience. The company has raised significant investment, achieving a valuation of $1 billion.
Built Robotics
Series C in 2022
Built Robotics Inc. develops automation technology solutions for the construction industry, focusing on transforming heavy equipment into autonomous robots. Founded in 2016 and headquartered in San Francisco, the company utilizes AI guidance systems that integrate various sensors, including GPS, cameras, and Lidar, with advanced software. These systems are retrofitted onto earthmoving equipment, allowing machines to operate fully autonomously. Built Robotics' technology is employed in building critical infrastructure such as wind farms, oil and gas pipelines, mining operations, and new housing developments. By automating repetitive tasks, the company addresses workforce shortages in sectors like solar energy, thus contributing to the transition to clean energy.
Timescale
Series C in 2022
Timescale is a modern cloud platform built on PostgreSQL, specializing in time-series data, events, and analytics. It provides an open-source SQL database designed to handle large-scale data and complex queries, making it particularly suited for applications involving the Internet of Things (IoT). By integrating directly into the query planner and execution engine, Timescale enhances performance through advanced distributed query optimizations. This enables users to effectively organize, store, analyze, and derive insights from time-series and machine data. With a global workforce and strong backing from prominent investors, Timescale aims to empower software developers and businesses around the world to innovate in computing.
Beyond Identity
Series C in 2022
Beyond Identity, Inc. offers a cloud-native passwordless identity management platform that enhances secure authentication by replacing traditional passwords with X.509-based certificates. Founded in 2019 and based in New York, the company provides a comprehensive suite of features including frictionless login, biometric authentication, and Single Sign-On (SSO) integration for various users such as employees, contractors, and suppliers. Its innovative approach utilizes asymmetric-key cryptography to create a robust Chain of Trust, which incorporates user and device identities along with real-time security posture assessments for adaptive risk-based authentication. This technology not only improves security by eliminating credential-stuffing attacks but also facilitates increased business agility and efficiency, allowing organizations to adopt new business models and significantly reduce operational costs while achieving complete passwordless identity management.
FTX
Series C in 2022
FTX Exchange is a cryptocurrency exchange that offers a platform designed for both professional trading firms and novice users. It provides a range of products, including quarterly and perpetual futures for various cryptocurrencies, leveraged tokens, and over-the-counter trading. The exchange was initially developed by Alameda Research, a leading provider of cryptocurrency liquidity, which contributed to its robust market presence from the outset. Additionally, FTX Ventures served as the corporate venture capital arm of FTX, investing in various sectors such as healthcare, information technology, and gaming. Founded in 2022, FTX Ventures aimed to support innovative startups without imposing restrictions on their decision-making processes. However, the company declared bankruptcy in November 2022, marking a significant downturn in its operations.
Virtru
Series C in 2022
Virtru is a data security company based in Washington, D.C., founded in 2012. It offers a data protection platform that enables organizations to secure sensitive information while ensuring ease of use. The platform supports compliance with various regulations, including HIPAA, FERPA, CJIS, and ITAR, allowing businesses to maintain control over their data throughout its lifecycle—from creation and storage to sharing and analysis. Virtru is known for its development of the Trusted Data Format (TDF), an open industry standard for persistent data protection. More than 20,000 organizations across diverse sectors rely on Virtru's privacy technologies to safeguard their data.
Incarey
Series C in 2021
InCarey is a leading domestic comprehensive service platform focusing on the management of patients with chronic diseases and vertical diseases. It is committed to providing one-stop Internet medical, pharmaceutical, and medical services for patients with long-term, heavy-service, and high-value chronic diseases. Innovative payment services.
Forethought
Series C in 2021
Forethought, founded in 2018, specializes in generative AI solutions aimed at enhancing customer service automation. The company offers tools that improve efficiency by integrating AI, particularly Large Language Models, into various stages of the customer support process. These tools facilitate immediate responses to customer inquiries, automate the handling of routine issues, and assist support agents with relevant information. By streamlining workflows and providing actionable insights, Forethought enables businesses to reduce resolution times and boost agent productivity, ultimately creating a more seamless customer experience.
Anyscale
Series C in 2021
Anyscale, Inc. is a technology company based in Berkeley, California, founded by the creators of the open-source project Ray. It specializes in developing distributed programming platforms and tools that simplify the creation and scaling of artificial intelligence applications. Anyscale's software enables developers and machine learning engineers to effortlessly scale their applications from local environments to the cloud, eliminating the need for complex infrastructure. The company's framework allows users of varying skill levels to build and deploy compute-intensive applications efficiently, facilitating faster and more cost-effective market entry for AI products. Anyscale aims to enhance the end-to-end AI lifecycle, making it accessible for organizations to leverage AI technologies.
Block Renovation
Series C in 2021
Block Renovation is a renovation platform that combines architect-grade design, construction labor, and materials into a streamlined renovation experience. Block’s mission is to give homeowners a better way to improve the spaces they live in, and to give contractors a better way to work. Founded by Koda Wang and Luke Sherwin, Block simplifies a complex and convoluted process and delivers an intuitive experience for completing a beautiful home renovation.
Stride Health
Series C in 2021
Stride Health, Inc. operates a health benefits platform tailored for independent workers and part-time employees in the United States. The company provides a range of affordable health coverage options, including dental plans, doctor visits, and prescription insurance. By simplifying the enrollment process, Stride Health enables users to quickly select their most cost-effective health plans while also offering assistance from personal advisors to help navigate any complexities. Founded in 2013 and based in San Francisco, California, Stride Health was previously known as Covered, Inc. The company's mission is to make health insurance more accessible and manageable for those who may not have traditional employment benefits.
Clarifai
Series C in 2021
Clarifai, Inc. is a prominent provider of advanced artificial intelligence solutions specializing in image recognition, natural language processing, and audio recognition. Founded in 2013 by Matt Zeiler, Ph.D., the company develops a deep learning platform that enables organizations to convert unstructured data—such as images, videos, text, and audio—into structured data efficiently and accurately. Clarifai's image recognition technology is capable of detecting near-duplicates, categorizing objects, and tagging images, while also allowing users to search for similar images within extensive uncategorized collections through a combination of semantic and visual similarity. Additionally, the company offers a labeling tool called Labeler, which aids in dataset labeling, AI training, and model auto-scaling in production environments. Headquartered in New York, with an office in Tallinn, Estonia, Clarifai employs a distributed team across various countries, including the United States, Canada, Argentina, and India.
Sisu
Series C in 2021
Sisu is a decision intelligence engine that allows users to efficiently and comprehensively utilize their cloud data. Companies such as Mastercard, Autodesk, Samsung, Upwork, Wayfair, Equinox, Udacity, and Gusto leverage Sisu to enhance their customer experiences, increase revenue growth, and reduce incident rates.
Pager
Series C in 2021
Pager, Inc. operates an on-demand service platform that connects patients with healthcare services in various settings, including their homes, offices, and hotels. The company offers a mobile application that addresses urgent care needs such as infections, fevers, and allergies, while also providing services like nurse chat, teleconsultations, screening, vaccinations, and prescription delivery. Pager aims to improve healthcare access and decision-making by employing a flexible platform that serves health plans and systems, enhancing consumer experience through information, guidance, and coordination. By integrating clinical and service teams with advanced technology, Pager facilitates triage, telemedicine, appointment scheduling, and health advocacy, fostering a comprehensive care experience. The company, incorporated in 2013 and based in New York, supports over 15 million covered lives in the United States and Latin America.
Allay Therapeutics
Series C in 2021
Allay Therapeutics is focused on developing innovative pain management solutions aimed at improving post-surgical recovery for patients. The company utilizes a proprietary technology platform that integrates validated non-opioid analgesics with biopolymers to create dissolvable therapeutic products. These products are designed to deliver targeted pain relief at the surgical site over extended periods, significantly longer than conventional pain treatments. Allay's lead investigational product, ATX101, is currently undergoing evaluation in a Phase 2 clinical trial for total knee arthroplasty surgeries. With a team of experienced entrepreneurs, scientists, and clinicians based in the San Francisco Bay Area and Singapore, Allay Therapeutics is dedicated to transforming the approach to pain management and addressing the limitations associated with opioid use.
Tulip Interfaces
Series C in 2021
Tulip Interfaces, Inc. specializes in creating applications for the manufacturing industry that enhance shop floor operations. Founded in 2012 and based in Somerville, Massachusetts, the company offers a no-code platform that allows organizations to integrate data from various sources, including sensors and existing equipment. This integration facilitates the creation of digital work instructions and provides real-time visibility into operations, including the performance of personnel and machinery. Tulip serves a diverse range of industries, including consumer electronics, pharmaceuticals, apparel, and medical devices, helping companies improve productivity, quality, and operational efficiency. By leveraging advanced technologies such as intelligent hardware sensors, computer vision, and machine learning, Tulip's platform enables organizations to digitally transform their operations and achieve better end-to-end traceability.
ARRIS
Series C in 2021
ARRIS specializes in additive molding technology for creating advanced performance composites tailored for mass-market applications such as aerospace, automotive, and consumer products. The company’s innovative manufacturing process focuses on the precise alignment of continuous carbon fibers, allowing for the integration of electronic components and multifunctional materials into a single, topologically optimized part. This technology enables clients to leverage high-performance composites, enhancing the capabilities and efficiency of their products while meeting the demands of modern manufacturing.
Aetion
Series C in 2021
Aetion, Inc. is a healthcare analytics company that specializes in generating real-world evidence (RWE) through its Aetion Evidence Platform. This platform analyzes data from diverse clinical and financial interactions within the healthcare system, including claims, electronic health records, and clinical trials. By utilizing its patented rapid-cycle analytics technology, Aetion provides valuable insights to life sciences companies, payers, and healthcare providers, enabling them to assess the effectiveness and value of medical treatments. This facilitates collaboration among stakeholders to make informed decisions regarding patient care that is both clinically effective and cost-efficient. Founded in 2012 and headquartered in New York City, Aetion has established partnerships with various investors and organizations, including a strategic collaboration with McKesson. The company caters to a global clientele, including biopharmaceutical firms and academic institutions.
Arcellx
Series C in 2021
Arcellx is a clinical-stage biotechnology company focused on developing innovative cell therapies for patients with cancer and other incurable diseases. The company aims to enhance the safety, effectiveness, and accessibility of these therapies. Its lead product candidate, CART-ddBCMA, targets relapsed or refractory multiple myeloma and is currently undergoing a Phase 1 clinical study. This therapy has received multiple designations from the U.S. Food and Drug Administration, including Fast Track and Orphan Drug status. Additionally, Arcellx is advancing its controllable CAR-T therapy, ARC-SparX, through two clinical programs aimed at treating relapsed or refractory multiple myeloma and acute myeloid leukemia.
Cleo
Series C in 2021
Cleo is a family support system that employers offer working parents, by helping families navigate their journey from fertility, to pregnancy, to parenting of newborns, infants, toddlers, and children to age 5. Employers choose Cleo as a strategic partner to power their culture transformation and see increased employee retention, more diverse and inclusive workplaces, and reduced health claims. Cleo supports parents globally in 50+ countries and works with forward-thinking companies like eBay, LinkedIn, Uber, and Straus Family Creamery and many others. Cleo is headquartered in San Francisco and is backed by Felicis Ventures, Forerunner Ventures, Greylock Partners, and NEA. Learn more at hicleo.com.
Monte Rosa Therapeutics
Series C in 2021
Monte Rosa Therapeutics is a biotechnology company focused on developing innovative cancer therapeutics that utilize molecular glue degraders (MGDs) to modulate protein degradation pathways. By leveraging the body's natural mechanisms for protein destruction, these small molecule drugs selectively target and degrade disease-causing proteins. The company employs its QuEEN platform, which combines artificial intelligence and proprietary experimental tools, to identify relevant proteins for degradation. With a diverse library of over 50,000 MGD molecules, Monte Rosa's lead candidate, MRT-2359, specifically targets the translation termination factor protein GSPT1, showing promise for treating MYC-driven tumors. The company aims to advance its pipeline of pioneering therapies for cancer and other diseases.
Nuvolo
Series C in 2021
Nuvolo is an EAM platform that delivers a simple, intuitive, and user-friendly online and offline mobile experience. It is revolutionizing enterprise asset management by innovating on ServiceNow, an enterprise cloud platform. The company’s vision is to be the global leader in cloud-based EAM, powered by a culture of innovation and a relentless commitment to customer service. Fully optimized for growing, mobile workforces worldwide, Nuvolo delivers a simple, intuitive, and user-friendly online and offline mobile experience. It was founded in 2013 and is headquartered in Paramus, New Jersey with offices throughout the U.S. and internationally in London and Pune, India.
Burrow
Series C in 2021
Burrow, Inc. is a New York-based furniture company that designs, manufactures, and supplies a range of home furnishings, including customizable sofas, sectionals, loveseats, armchairs, and ottomans, as well as tables, rugs, and various accessories. Founded in 2016, Burrow focuses on creating luxury furniture that is both easy to move and comfortable, utilizing sustainably-sourced hardwood and non-toxic, scratch- and stain-resistant fabrics. The company aims to reinvent the home furnishing experience by offering personalized and durable products that allow customers to avoid traditional retail markups. Burrow sells its items through physical showrooms in several states, including Washington, Massachusetts, Texas, and California, as well as through its online platform. The company's manufacturing facility is located in Mexico City, Mexico.
Personal Genome Diagnostics
Series C in 2021
Personal Genome Diagnostics, Inc. specializes in patient-specific cancer genome analysis using advanced digital characterization and monitoring technologies. Founded in 2010 and based in Baltimore, Maryland, the company offers a range of products and services aimed at improving cancer diagnosis and treatment. Their METDetect Assay detects MET gene amplifications in cancer patients' circulation, providing detailed reports on tumor-specific alterations. The LungSelect product identifies actionable genetic changes in plasma from non-small cell lung cancer patients, while PGDx elio plasma resolve is a diagnostic test that detects various genetic alterations in circulating cell-free DNA. Additionally, the company offers RNAcomplete, which allows for the extraction of total RNA and genomic DNA from single tissue samples, and CancerXOME, which analyzes the coding regions of numerous genes. Personal Genome Diagnostics collaborates with institutions like Mayo Clinic and has partnerships with KingMed Diagnostics to further enhance cancer genome research and diagnostics.
Sitetracker
Series C in 2021
Sitetracker is a software-as-a-service (SaaS) platform that specializes in managing the deployment, operation, and servicing of critical infrastructure and technology. It offers a comprehensive solution for optimizing the entire asset lifecycle, incorporating features such as artificial intelligence, automation, and actionable analytics. The platform supports stakeholders in planning, deploying, maintaining, and growing their capital asset portfolios effectively. Sitetracker is particularly beneficial for industries with high-volume, repeatable projects, such as telecommunications, alternative energy, and utilities. Major companies in these sectors, including Ericsson, Fortis, Google, British Telecom, and Vodafone, utilize Sitetracker to manage extensive projects and assets, collectively valued at over $25 billion worldwide. The platform also facilitates capacity planning and vendor analytics, helping organizations identify staffing needs and resource bottlenecks while connecting project timelines with historical performance data.
KONUX
Series C in 2021
KONUX GmbH, founded in 2014 and based in Munich, Germany, specializes in the development of Industrial Internet of Things (IIoT) solutions that integrate smart sensor systems with artificial intelligence-based analytics. The company's offerings include switch monitoring, asset monitoring, rolling stock monitoring, anomaly detection, and predictive analytics, all aimed at enhancing railway and industrial operations. By providing real-time monitoring and predictive maintenance capabilities, KONUX helps clients improve the reliability, capacity, and cost-efficiency of their railway systems. The company has expanded its reach across multiple countries in Europe and Asia and has been recognized by the World Economic Forum as one of the world's most innovative start-ups. With over $130 million raised from leading investors, KONUX is committed to modernizing railroad operations and contributing to a sustainable future in mobility.
Bestow
Series C in 2020
Bestow Inc. is a digital insurance company based in Dallas, Texas, specializing in life insurance services. Founded in 2016 by Jonathan Abelmann and Melbourne O'Banion, Bestow leverages data-driven technology and algorithmic underwriting to assess risks efficiently. The company partners with prominent life insurance carriers to enhance financial stability for individuals by streamlining processes from origination and underwriting to administration. Bestow aims to reduce costs and maximize efficiency in the life insurance sector, positioning itself as a leading platform in this market.
Alfred
Series C in 2020
Founded in 2014 by Marcela Sapone and Jessica Beck, Alfred is the largest and most advanced residential management platform. Since its inception, Alfred has focused on providing a resident-first experience. With an unparalleled knowledge of what residents want and technology that boosts income and efficiency for owners and operators, Alfred provides a single stop that elevates the rental ecosystem for all involved. Named by Fast Company as one of the Top 50 Most Innovative Companies, Alfred’s AOS technology drives lower operating costs and higher returns for property owners and operators. Through strategic partnerships with international real-estate owners and operators such as Hines, Related, RXR, Greystar, Invesco, Brookfield and J.P. Morgan, With RKW, Alfred’s portfolio now extends to more than 300,000 residents in 44 cities across the U.S. and Canada and has planned expansions in Europe, Israel and Asia.
Willow
Series C in 2020
Willow, founded in 2014 and based in Mountain View, California, is a company that specializes in the development and manufacturing of wearable breast pumps and related breastfeeding products. The company offers a range of items including in-bra breast pumps, milk bags, replacement parts, pumping bras, and accessories like flanges and chargers. Willow's breast pumps are designed to be mobile and hands-free, allowing mothers to pump discreetly and conveniently. The devices are cordless, spill-proof, and equipped with a mobile application that tracks milk output, facilitating a hassle-free pumping experience for mothers on the go.
Everactive
Series C in 2020
Everactive, Inc., also known as Everactive Insights, Inc., specializes in the development of wireless sensing devices and technologies tailored for Industrial Internet of Things (IoT) applications. The company produces ultra-low-power chips that enable battery-less wireless sensors, facilitating data generation and analytics for various industrial operations. Its innovations include PsiKick integrated circuits, which support programmable processing, power management, and RF communication. Everactive's solutions encompass steam trap monitoring, flare system monitoring, and machine health monitoring, allowing for continuous analysis of industrial assets. Founded in 2012 and headquartered in Santa Clara, California, Everactive also has locations in Charlottesville, Virginia, and Ann Arbor, Michigan. The company’s technology is based on energy harvesting, enabling low-cost and long-lived instrumentation that supports sustainable and scalable IoT applications.
Amplyx Pharmaceuticals
Series C in 2020
Amplyx Pharmaceuticals is a pre-clinical stage company focusing on the development of small molecule drugs with enhanced efficacy and lower toxicity. Amplyx employs a platform approach to improve small molecule drugs by the addition of a second small molecule to an existing drug. The company develops innovative therapies for debilitating and life-threatening diseases that affect people with compromised immune systems. Amplyx Pharmaceuticals was founded in 2006 and is headquartered in San Diego, California.
Willow
Series C in 2019
Willow, founded in 2014 and based in Mountain View, California, is a company that specializes in the development and manufacturing of wearable breast pumps and related breastfeeding products. The company offers a range of items including in-bra breast pumps, milk bags, replacement parts, pumping bras, and accessories like flanges and chargers. Willow's breast pumps are designed to be mobile and hands-free, allowing mothers to pump discreetly and conveniently. The devices are cordless, spill-proof, and equipped with a mobile application that tracks milk output, facilitating a hassle-free pumping experience for mothers on the go.
ChromaCode
Series C in 2019
ChromaCode, Inc. is a molecular diagnostics company based in Carlsbad, California, founded in 2012. The company specializes in developing innovative testing solutions for infectious diseases, cancer, and non-invasive prenatal testing (NIPT) by utilizing patented mathematical methods and algorithmic enhancements. ChromaCode's products significantly enhance the multiplexing capabilities of quantitative polymerase chain reaction (qPCR) instruments, allowing laboratories to perform cost-effective testing of multiple targets from a single sample. Their offerings include software, reagents, and assays that improve signal processing and overall assay performance, making diagnostics more accessible and efficient. Among their notable products is the HDPCR Tick-Borne Pathogen Panel, a multiplex test that detects various tick-borne pathogens in one assay.
Black Diamond Therapeutics
Series C in 2019
Black Diamond Therapeutics is a precision oncology medicine company focused on discovering and developing small molecule therapies that are tumor-agnostic. The company’s lead product candidate, BDTX-189, targets non-canonical and oncogenic mutations in ErbB kinases, specifically the epidermal growth factor receptor and tyrosine-protein kinase. In addition to BDTX-189, Black Diamond is developing allosteric-EGFR mutation inhibitors and other early-stage pipeline programs that address allosteric mutations in kinases associated with cancer and rare genetic diseases. The company's approach is centered on its Mutation-Allostery-Pharmacology platform, which aims to create targeted treatments for genetically defined cancers, especially for patients with limited existing treatment options. Founded in 2014 and headquartered in Cambridge, Massachusetts, Black Diamond Therapeutics was previously known as ASET Therapeutics until its name change in January 2018.
Sentry
Series C in 2019
Sentry is an open-source platform focused on improving workflow productivity through application monitoring. It aggregates data on errors and crashes across software stacks, providing real-time visibility into each incident as it occurs. The platform delivers essential details needed to prioritize and identify issues, along with insights into deployments and guidance for reproduction and resolution of crashes. By allowing organizations to pinpoint which errors have the greatest impact on their operations, Sentry helps users understand how these issues affect their overall performance and profitability.
PlayVS
Series C in 2019
PlayVS operates an esports platform designed to facilitate competitive gaming for high school students. The platform enables the organization of online tournaments where teens can form teams at their schools and compete against teams from other schools for cash prizes and titles at state championships. It serves as a comprehensive resource for high school esports programs, keeping participants informed and engaged in the competitive gaming landscape.
Echodyne
Series C in 2019
Echodyne is a company that specializes in the development and manufacture of radar technologies based on metamaterials. Founded in 2014 and headquartered in Kirkland, Washington, Echodyne integrates its patented metamaterials technology with advanced software to produce a high-performance radar platform. This technology offers enhanced radar vision, combining agile imaging radar hardware with sophisticated software for tasks such as classification, recognition, and perception. As a result, Echodyne provides solutions for security and machine autonomy across various sectors, including government, defense, and industry. Its radar systems enable the safe operation of autonomous machines, such as drones, cars, trucks, and heavy equipment, in diverse weather conditions.
Heap
Series C in 2019
Heap automates away the annoying parts of analytics so that companies can focus on making smarter business decisions. The company's mission is to power business decisions with truth. It encourages companies to focus on discovering insights and taking action. With Heap, organizations can remove technical jams and obtain a single comprehensive view of the customers. The software automatically gathers, organizes, analyzes, and connects customer data, so businesses can create more valuable products and experiences. Heap serves over 6,000 companies in ecommerce, SaaS, fintech, retail, media, and beyond including Twilio, LendingClub, App Annie, Optimizely, Morningstar, Monotype, and Casper. Heap was founded on 2013 and is headquartered in San Francisco, California.
Expel
Series C in 2019
Expel, Inc. is a managed security operations provider based in Herndon, Virginia, specializing in managed detection and response (MDR) services. Founded in 2016, the company offers a comprehensive security operations center (SOC)-as-a-service that monitors and responds to threats across cloud, hybrid, and on-premises environments. Expel's platform combines advanced technology with human expertise to quickly detect, analyze, and remediate security issues, including phishing, ransomware, and supply chain attacks. The Expel Workbench™ platform enhances collaboration by allowing customers to engage with live investigations and receive continuous updates, ensuring transparency throughout the security process. By filtering out false positives, Expel enables security teams to focus on strategic priorities rather than being overwhelmed by alerts, ultimately improving their overall security posture.
Tamara Mellon
Series C in 2019
Tamara Mellon, LLC specializes in offering women's apparel and accessories, including a diverse range of footwear such as sandals, boots, pumps, flats, and legging boots. The company also features designer handbags and ready-to-wear clothing, which encompasses dresses, jumpsuits, tops, knitwear, pants, skirts, and outerwear. Founded in 2011 by Tamara Mellon and Jill Layfield, the company is headquartered in New York City and sells its products through both retail and online channels in the United States and internationally. In addition to its fashion offerings, Tamara Mellon provides a complimentary cobbler service for two years after purchase, enhancing the customer experience by ensuring the durability and maintenance of its handcrafted footwear.
Expanse
Series C in 2019
Expanse, Inc. is an enterprise software company based in San Francisco, California, that specializes in data marshalling services and IT operations management. Founded in 2012 and originally known as Qadium, Inc., the company provides organizations with an updated view of their internet-connected assets, enabling IT and security teams to monitor their global attack surface. Expanse's platform indexes global IP addresses, DNS protocol information, and other registration records, allowing organizations to discover unknown assets and manage their exposure to online threats. Trusted by major enterprises and government agencies, Expanse's technology enhances awareness and visibility, significantly reducing the risks associated with internet-connected assets and improving overall cybersecurity posture.
Igneous
Series C in 2019
Igneous delivers the only Unstructured Data Management (UDM) as-a-Service solution, giving data-centric enterprises visibility, protection, and data mobility at scale. Igneous’ API-enabled, cloud-native solution combines all UDM functions so that organizations can tap the value of their unstructured data, while reducing risk and optimizing IT resource utilization. Kiran Bhageshpur and Byron Rakitzis founded the company in October 2013, with its headquarters in Seattle in Washington.
Trevi Therapeutics
Series C in 2019
Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in New Haven, Connecticut, dedicated to developing and commercializing nalbuphine ER, an oral extended-release formulation. The company is focused on treating serious neurologically mediated conditions, specifically chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis, and levodopa-induced dyskinesia in individuals with Parkinson's disease. Trevi is currently conducting a Phase 2b/3 clinical trial, known as the PRISM trial, for nalbuphine ER, targeting severe pruritus associated with prurigo nodularis. The conditions being addressed share similar underlying mechanisms that involve opioid receptors in both the central and peripheral nervous systems. Founded in 2011, Trevi Therapeutics aims to provide innovative treatment options for patients suffering from these challenging health issues.
Annexon Biosciences
Series C in 2018
Annexon Biosciences is a clinical-stage biopharmaceutical company focused on developing innovative therapies for patients suffering from classical complement-mediated disorders affecting the body, brain, and eye. The company's research is centered around its platform technology that targets classical complement-mediated autoimmune and neurodegenerative diseases associated with the abnormal activation of C1q, a key molecule in the classical complement pathway. Annexon's lead product candidate, ANX005, is a full-length monoclonal antibody intended for intravenous use in treating autoimmune and neurodegenerative disorders. Another candidate, ANX007, is a monoclonal antibody Fab formulated for intravitreal administration aimed at neurodegenerative ophthalmic conditions. The company employs a disciplined, biomarker-driven development strategy to ensure its therapies effectively engage the target at tolerable doses within the intended patient tissues, while also exploring additional indications within both orphan and larger market segments.
The Wing
Series C in 2018
The Wing is a network of work and community spaces designed for women with locations in New York, California, and Washington, D.C. The Wing’s mission is the professional, civic, social, and economic advancement of women through the community.
Plaid
Series C in 2018
Plaid Inc. is a technology platform that facilitates the connection between consumers' bank accounts and various financial applications. Founded in 2012 and headquartered in San Francisco, the company aims to democratize financial services by providing developers with tools and infrastructure to create innovative financial products. Plaid's offerings include a suite of APIs that allow access to detailed transaction histories, real-time account balances, and user identity verification, among other functionalities. These tools enable financial institutions and developers, ranging from startups to large corporations, to build secure and user-friendly applications for personal finance, consumer payments, lending, and more. By streamlining the integration with traditional banking systems, Plaid enhances the ability of consumers and businesses to manage their financial activities efficiently.
NeueHealth
Series C in 2018
NeueHealth Inc is a healthcare company dedicated to providing high-quality, coordinated care to all health consumers, particularly those in aging and underserved populations. The company focuses on making healthcare accessible and affordable through strategic partnerships with providers and payors, aligning their interests to enhance the overall healthcare experience. By leveraging technology and data analytics, NeueHealth offers a suite of services that empower independent providers and medical groups to succeed in performance-based arrangements. This approach not only optimizes clinical outcomes but also aims to drive down costs and reduce systemic waste, ultimately delivering a more personalized and efficient healthcare experience for its members across various insurance markets, including the ACA Marketplace, Medicare, and Medicaid.
Infoworks.io
Series C in 2018
Infoworks.io, Inc. is an enterprise software company that specializes in automated data management solutions for organizations managing large-scale data environments. Founded in 2014 and headquartered in Palo Alto, California, with an additional office in Bengaluru, India, the company offers DataFoundry, a tool designed to streamline data operations and orchestration. This platform facilitates the discovery, loading, organization, and management of data on Hadoop, enabling enterprises to consolidate their data and manage workflows efficiently from ingestion to analytics. Infoworks' solutions encompass various aspects of data management, including ingestion, synchronization, preparation, and orchestration, which significantly accelerate cloud migration and modernize data operations. By automating these processes, Infoworks enables organizations to unlock the value of their data while improving delivery speed for AI, machine learning, and analytics applications.
HEAVY.AI
Series C in 2018
HEAVY.AI develops a big data analytics and visualization platform that helps businesses and government entities uncover valuable opportunities and risks within extensive location and time data. Its technology leverages the capabilities of modern GPU and CPU hardware to facilitate high-speed analytics and visualization. The platform features a structured query language-compliant database and an advanced visual analytics engine, allowing users to analyze and visualize large datasets efficiently. Clients from various sectors, including government, telecommunications, energy, utilities, and higher education, utilize HEAVY.AI's solutions to enhance decision-making processes and gain insights from multi-billion record datasets.
Enigma
Series C in 2018
Enigma Technologies, Inc. is a New York-based operational data management and intelligence company that focuses on providing a searchable database of public records and information to enhance decision-making and streamline operations. The company offers a suite of products including Enigma Data Infrastructure, which features tools for data operations and metadata improvement, and Enigma Solutions tailored for industries such as financial services, healthcare, and insurance. Additionally, Enigma provides analysis-ready public data across various sectors, as well as a repository of public information. Enigma Labs fosters collaboration to develop open data tools for public use, while the company’s application programming interface (API) enables developers to create data-rich applications and services. Enigma's offerings also include specialized data services like entity resolution and geocoding. Founded in 2011, Enigma serves notable organizations such as American Express and PayPal, providing insights into the identity, activity, and risk profiles of small businesses.
StreamSets
Series C in 2018
StreamSets software delivers performance management for data flows that feed the next generation of big data applications. Its mission is to bring operational excellence to the management of data in motion, so that data continually arrives on-time and with quality, empowering business-critical analysis and decision-making. It was founded in 2014 and headquartered in San Francisco, California.
MORE Health
Series C in 2018
MORE Health, Inc. operates a cloud-based physician collaboration platform aimed at connecting patients' attending doctors with specialists to collaboratively develop accurate diagnoses and optimal treatment plans. The platform encompasses a comprehensive clinical database, including medical history, hospital records, lab results, and medical imaging, as well as discussion tools that facilitate HIPAA-compliant video conferencing. In addition to these features, MORE Health offers a patient portal for personal health records, an Overseas Co-Diagnosis service for international patients, and a Secure Medical Record service for traveling employees. Initially launched as a concierge service for private clients, the company now provides its services as a supplemental health benefit for U.S. companies, allowing employees to access high-quality medical consultations, including co-diagnoses and independent second opinions. Founded in 2013 and based in Foster City, California, MORE Health has established strategic alliances with notable medical institutions, aiming to serve patients globally and provide access to top medical expertise during critical health decision-making.
Brandless
Series C in 2018
Brandless, Inc. is an online consumer commerce platform based in San Francisco, California, that offers a diverse range of products across several categories. Founded in 2015, the company sells food items such as snacks, granola, and baby food, as well as home essentials including cleaning supplies, tableware, and office products. Additionally, Brandless provides beauty and personal care items, health and wellness products like vitamins and supplements, baby products, and pet supplies. The company aims to create a marketplace that empowers consumers to make healthier and more sustainable choices for themselves, their families, and the environment by prioritizing quality and collaboration.
Tuya
Series C in 2018
Tuya is a global "AI+IoT" developer platform, and the world's leading voice AI interactive platform, connecting consumers, manufacturing brands, OEMs and retail chains, providing customers with a one-stop artificial intelligence Internet of Things solution, and covering hardware access, cloud services and App development, forming a closed loop of AI + manufacturing, providing technology and business model upgrade services for business with consumer IoT smart devices, in order to meet consumers' higher demands for hardware products. As of the end of October 2018, Tuya Smart has served 93,000 customers worldwide, connecting more than 100 million smart products in the market, creating a completely neutral "AI+IoT" model for empowering products, with total product listings of more than 30,000, selling to nearly 200 countries and regions. On the global IoT cloud platform with a distributed architecture, the daily processing device requests have reached nearly 50 billion times, daily voice AI interaction has exceeded 20 million times, and the accumulated data volume has reached 15 petabytes.
Framebridge
Series C in 2018
Framebridge is a custom framing startup that provides an online custom framing service. The company has tackled the painful, inconvenient and costly process of custom framing an item, replacing it with an experience that places the customer first. Through a tech-forward experience and an obsessive focus on quality and materials, they have introduced a new generation of customers to the tradition of custom manufacturing. Framebridge customers can choose from a curated selection of on-trend frame styles, then upload their photos to the Framebridge website, or ship their items directly to Framebridge in prepaid packaging. The expert team at Framebridge will receive their items and handcraft beautiful custom frames to each customer's exact specifications. The finished pieces ship directly to consumers, arriving in days, ready to hang. Framebridge's transparent pricing, which is determined by the size of each item, begins at $39 and includes free shipping. Framebridge launched in 2014 as a solution to founder Susan Tynan’s ongoing frustration over getting her travel art custom framed. Framebridge investors include New Enterprise Associates (NEA), Revolution Ventures, and SWaN & Legend Venture Partners, as well as seasoned retail and technology executives with industry experience at Crate & Barrel, Rent the Runway, and LivingSocial. The company is headquartered in Washington, DC and operates manufacturing facilities in Richmond, KY, and Lanham, MD.
NGINX
Series C in 2018
NGINX, now part of F5, is a company headquartered in San Francisco, California, specializing in technologies that support the development and delivery of modern applications. Established in 2011, NGINX is renowned for its high-performance load balancer, web server, and reverse proxy, all of which are part of its open-source offerings. The company’s platform facilitates multi-cloud application services, catering to developers' needs for ease-of-use and flexibility while meeting the demands of network operations teams for scale, security, and reliability. NGINX plays a crucial role in helping enterprises modernize legacy applications and implement new microservices-based architectures, thus supporting organizations in their digital transformation efforts.
Metacrine
Series C in 2018
Metacrine is a clinical-stage biopharmaceutical company focused on building an innovative pipeline of best-in-class drugs to treat liver and gastrointestinal (GI) diseases. The most advanced program is focused on the farnesoid X receptor (FXR) an important drug target in multiple liver and GI diseases. Beyond the FXR program, a pipeline of novel drug candidates against other drug targets is being explored by taking advantage of internal drug discovery and development capabilities.
Intact Vascular
Series C in 2018
Intact Vascular, Inc. is a medical device company based in Wayne, Pennsylvania, focused on developing minimally invasive products for peripheral vascular procedures. Established in 2011, the company is known for its Tack Endovascular System, which enhances the results of peripheral balloon angioplasty in treating peripheral arterial disease (PAD) and critical limb ischemia (CLI). This innovative technology aims to improve clinical outcomes and quality of life for patients suffering from vascular diseases, offering physicians a new and effective treatment option. Intact Vascular is dedicated to creating safe, efficacious, and user-friendly medical devices for healthcare providers and their patients.
Goop
Series C in 2018
Goop Inc. is a lifestyle brand that operates an online platform offering wellness advice, curated shopping, and lifestyle content. Founded in 2008 by Gwyneth Paltrow, Goop began as a newsletter sharing travel recommendations, health-focused recipes, and shopping finds, which has since evolved into a comprehensive lifestyle site. The platform features a selection of products including apparel, beauty items, skincare, and home goods, all sourced with an emphasis on quality and wellness. In addition to retail, Goop provides a wealth of digital content, such as beauty and makeup tips, cooking recipes, and wellness advice, along with travel information and design inspiration. By connecting its audience with expert insights and curated product offerings, Goop positions itself as a trusted resource for lifestyle enhancement.
DataVisor
Series C in 2018
DataVisor Inc. is a company specializing in fraud and financial crime detection solutions, established in 2013 and located in Mountain View, California. The firm employs advanced unsupervised machine learning technology to predict and identify attack vectors, effectively protecting large consumer-facing organizations from various digital threats. Its key products include dCube, which enables proactive fraud detection and prevention, and dVector, which enhances fraud management through accurate signal analysis. Additionally, dEdge collects real-time intelligence from connected devices to safeguard mobile and web applications against sophisticated attacks. DataVisor addresses a wide range of fraud types, including account takeovers, fake account creations, money laundering, and promotional abuse, serving industries such as financial services, retail, e-commerce, social platforms, and telecommunications. The company's innovative approach enables organizations to respond to rapidly evolving fraud tactics and mitigate risks in real time.
Fire1
Series C in 2018
FIRE1 and is based in Dublin, Ireland, will focus on developing novel therapeutic devices.
Metavention
Series C in 2018
Metavention, Inc., incorporated in 2012 and based in Dover, Delaware, focuses on innovative treatments aimed at addressing metabolic diseases linked to overactive sympathetic nerves. The company has developed a renal denervation procedure utilizing its IRF denervation system, which applies radio frequency energy to specifically target these nerves. This approach is designed to provide a permanent solution for conditions such as high blood pressure and complications associated with Type 2 diabetes, including elevated glucose levels and abnormal liver function. By employing trans-catheter devices that leverage standard interventional vascular techniques, Metavention equips medical practitioners with effective tools for diagnosing and treating patients suffering from these metabolic disorders.
ThreatQuotient
Series C in 2017
ThreatQuotient, Inc. is a cybersecurity company that specializes in developing a threat intelligence platform designed to help organizations effectively manage and respond to cyber threats. Founded in 2013 and headquartered in Reston, Virginia, the company offers its flagship product, ThreatQ, which integrates and correlates various external threat sources with internal security solutions to provide contextualized intelligence. This platform streamlines security operations by reducing noise, prioritizing threats, and facilitating collaboration among teams. It features capabilities such as Indicator Nurturing, which tailors indicators of compromise to specific infrastructures, as well as integrations with existing security tools and processes. ThreatQuotient's solutions support a range of use cases, including incident response and threat hunting, ultimately enhancing the efficiency and effectiveness of security operations. The company has received multiple awards for its product excellence and industry leadership, reflecting its commitment to advancing cybersecurity practices. Additionally, ThreatQuotient operates internationally, with a presence in Germany and Australia.
Eargo
Series C in 2017
Eargo, Inc. is a consumer-focused medical device company based in San Jose, California, specializing in the design and development of hearing aids for individuals with hearing loss. Founded in 2010, Eargo offers a range of rechargeable hearing aids that can be controlled via smartphone, along with online hearing screenings and virtual support services to eliminate the need for in-person visits. The company's innovative approach aims to address common barriers to hearing aid adoption, such as social stigma, accessibility, and cost, thereby enhancing the quality of life for its users. Eargo sells its products directly to consumers through online platforms, positioning itself as a modern alternative to traditional hearing aid solutions.
Wheels Up Partners
Series C in 2017
Wheels Up is a membership-based private aviation company in the United States that aims to make private flying more accessible and affordable. It provides on-demand private aviation services through an innovative platform that connects consumers with safety-vetted aircraft. Members can book flights, manage their accounts, and explore ride-share options using a mobile app. Wheels Up offers a variety of travel alternatives through a combination of programmatic and charter services, utilizing both owned and leased aircraft as part of an asset-light model. Additionally, members can participate in the Wheels Down program, enhancing their overall experience. The company is dedicated to delivering flexibility, service, and safety in private aviation.
Tempus
Series C in 2017
Tempus is a technology company improving precision medicine through the practical application of artificial intelligence in healthcare. Their platform is designed to analyze and interpret clinical and molecular data to help healthcare providers deliver more personalized and effective treatments.
Raise
Series C in 2017
Raise is a digital payment platform that allows consumers to purchase discounted gift cards and earn savings on transactions across various retailers. The platform allows users to buy and sell gift cards, facilitating a marketplace where individuals can exchange unwanted gift cards for cash or other cards. Raise also offers a rewards program that enables customers to earn points on purchases, which can be redeemed for future savings. By partnering with numerous brands, Raise enhances consumer choice and accessibility to various products and services while promoting cost-effective shopping solutions.
Amplyx Pharmaceuticals
Series C in 2017
Amplyx Pharmaceuticals is a pre-clinical stage company focusing on the development of small molecule drugs with enhanced efficacy and lower toxicity. Amplyx employs a platform approach to improve small molecule drugs by the addition of a second small molecule to an existing drug. The company develops innovative therapies for debilitating and life-threatening diseases that affect people with compromised immune systems. Amplyx Pharmaceuticals was founded in 2006 and is headquartered in San Diego, California.
DataRobot
Series C in 2017
DataRobot, Inc. develops an automated machine learning platform that empowers enterprises to create predictive models efficiently. Its offerings include DataRobot Cloud, a predictive analytics solution available both in the cloud and on-premises, and DataRobot MLOps, which facilitates the deployment, monitoring, and management of machine learning models across organizations. The company also provides DataRobot Enterprise, featuring flexible deployment options, governance, and training services, along with packages designed to accelerate artificial intelligence projects. DataRobot serves a diverse range of industries, including banking, healthcare, manufacturing, and marketing, catering to business analysts, data scientists, and IT professionals. Founded in 2012 and headquartered in Boston, Massachusetts, DataRobot has expanded its operations globally, with offices in major cities such as London, Paris, and Tokyo, and maintains strategic partnerships to enhance its offerings.
Complexa
Series C in 2017
Complexa, Inc. is a biopharmaceutical company based in Berwyn, Pennsylvania, focused on developing treatments for severe and life-threatening diseases related to fibrosis and inflammation. Established in 2008, the company is advancing its lead compound, CXA-10, an oral nitrated fatty acid aimed at treating focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH). Complexa utilizes proprietary technologies that involve the synthesis of endogenous nitro-fatty acids, which serve as cell-signaling agents regulating key inflammatory pathways. This approach aims to enhance the body's natural mechanisms for resolving and repairing acute and chronic tissue injuries, with a focus on addressing various inflammatory, fibrotic, and central nervous system diseases.
Trevi Therapeutics
Series C in 2017
Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in New Haven, Connecticut, dedicated to developing and commercializing nalbuphine ER, an oral extended-release formulation. The company is focused on treating serious neurologically mediated conditions, specifically chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis, and levodopa-induced dyskinesia in individuals with Parkinson's disease. Trevi is currently conducting a Phase 2b/3 clinical trial, known as the PRISM trial, for nalbuphine ER, targeting severe pruritus associated with prurigo nodularis. The conditions being addressed share similar underlying mechanisms that involve opioid receptors in both the central and peripheral nervous systems. Founded in 2011, Trevi Therapeutics aims to provide innovative treatment options for patients suffering from these challenging health issues.
Segment
Series C in 2017
Segment provides the customer data infrastructure that helps businesses put their customers first. Using Segment, companies can collect, unify, and connect their first-party to over 200 marketing, analytics, and data warehouse tools. It was founded in 2011 and headquartered in San Francisco, California.
Transfix
Series C in 2017
Transfix, Inc. is a trucking brokerage firm based in New York that specializes in connecting shippers with carriers for freight transportation across the United States. Founded in 2010, the company has developed an online freight management platform that utilizes advanced algorithms and business intelligence to enhance supply chain visibility and efficiency. Transfix offers services such as real-time shipment tracking, carrier performance insights, and support tailored to various industries, including retail, food, beverage, and manufacturing. By leveraging its Intelligent Freight Platform, Transfix aims to optimize logistics processes, reduce empty miles, and improve overall supply chain performance for its clients.
Nightstar Therapeutics
Series C in 2017
NightstaRx Ltd. is a U.K. startup company. Gene therapy is the use of a gene to treat disease. The approach could enable treatments for a several rare conditions caused by mutations in a single gene.
Topia
Series C in 2017
Topia Limited is a provider of mobility management solutions that focuses on global talent mobility for businesses. Established in 2010 and headquartered in London, with an additional office in San Francisco, Topia offers a comprehensive platform that streamlines the entire talent mobility process. This includes relocation and expatriate administration, tax and immigration management, and payroll calculations. The company’s platform, known as Topia One, is a cloud-based system that integrates data standards across global talent mobility. Additionally, the Topia Go mobile application allows employees to manage their relocations and assignments effectively. Topia serves a diverse clientele, including well-known brands such as Dell, Schneider Electric, and Deliveroo, and has established strategic partnerships with organizations like Fragomen Worldwide and the Employee Mobility Institute. The company was previously known as MOVE Guides Limited until its rebranding in April 2018.
Movius
Series C in 2017
Movius Interactive provides cloud-based enterprise mobility solutions that enhance mobile communication for businesses and their clients. The company's Software-as-a-Service platform extends enterprise telecommunication services to mobile devices, enabling secure communication while ensuring corporate compliance. It allows users to manage their enterprise mobile communications through dedicated work phone lines across various devices. Movius also offers a range of pre-packaged applications and APIs for application development, alongside support and training services. Founded in 1999, Movius is headquartered in Atlanta, Georgia, with additional offices in Dubai, Madrid, Bengaluru, and Johannesburg, serving telecommunication providers, businesses, and end-users both in the United States and internationally.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.